Ruimin Chang

Central South University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index2.8kcitations77works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(22), Circular RNAs in diseases(18), RNA modifications and cancer(15), Cancer-related molecular mechanisms research(13), Ferroptosis and cancer prognosis(13)

Publications77 total

FMO3 as a novel prognostic biomarker and therapeutic target in non-small cell lung cancer by attenuating endoplasmic reticulum stress
2025Open Access
Efficacy and safety of the optimal immunochemotherapy regimen for resectable non-small cell lung cancer: A network meta-analysis of randomized controlled trials
Asian Journal of Surgery·2025Open Access
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning
Translational Cancer Research·2025Open Access
Updated perspectives on visceral pleural invasion in non-small cell lung cancer: A propensity score-matched analysis of the SEER database
Current Problems in Cancer·2025
Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma
Scientific Reports·2025· 1 citedOpen Access
The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study
Journal of Personalized Medicine·2024· 5 citedOpen Access
Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
Journal of Cancer Research and Clinical Oncology·2024· 8 citedOpen Access
Case report: A case of advanced gastric cancer with multiple skin metastases, with significant relief from immunotherapy
Frontiers in Immunology·2024· 5 citedOpen Access
RETRACTED: Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
Research Square (Research Square)·2024Open Access
Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy
Nano Research·2023· 12 cited
Supplementary Material and Methods from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Data from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary Tables from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary figure legends from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary Material and Methods from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary Tables from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Data from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary figure legends from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary figures from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
Supplementary figures from miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Lian‐Yue Yang(13), Hao Yang(8), Yuanda Cheng(8), Xizhe Li(7), Feng Fang(6), Jiangfeng Xu(5), Chunfang Zhang(5), Chunfang Zhang(5), Fang Fěng(4), Shuai Xiao(4), Zuozhong Xie(4), Xiaoyan Zhu(4), Chaojun Duan(4), Wolong Zhou(4), Yang Gao(4), Xiang Chen(4), Yuetao Zhao(4), Qulian Guo(3), Changsheng Huang(3), Yuanqi Liu(3)